Korea's chip fund makes first biotech bet, backing LigaChem with $323 million

▤ Summary

LigaChem Biosciences raised 500 billion won from Korea's National Growth Fund and other backers. The company plans to use the money to push selected ADC pipeline assets into later-stage clinical development, regulatory filings, and eventual commercialization. The deal marks the first direct equity investment by the fund in a biotech company after years of backing AI chip firms. LigaChem will keep its licensing model while adding in-house late-stage execution for priority programs.

$ Funding

▦ Linked Companies